CTABF News and Press, Canntab Therapeutics Ltd From 06/02/20

Canntab and Medipharm Labs Enter Into a Wholesale Tablet Purchase Agreement Canada NewsWire TORONTO, June 2, 2020 TORONTO , June 2, 2020 /CNW/ - Canntab Therapeutics Limited (CSE:PILL.CN)(OTCQB:CTABF) (FRA:TBF1.F) (the " Company " or " Canntab "), the leading innovat...

Canntab Appoints Joshi Laxminarayan as Chief Scientific Officer Canada NewsWire TORONTO, May 15, 2020 TORONTO , May 15, 2020 /CNW/ - Canntab Therapeutics Limited (CSE:PILL.CN)(OTCQB:CTABF) (FRA:TBF1.F) (the "Company" or "Canntab"), the leading innovator in cannabinoid and...

Canntab to Present at the Canaccord Genuity 2020 Virtual Cannabis Conference Canada NewsWire TORONTO, May 11, 2020 TORONTO , May 11, 2020 /CNW/ - Canntab Therapeutics Limited ( CSE:PILL.CN )( OTCQB:CTABF ) ( FRA:TBF1.F ) (the "Company" or "Canntab"), the leading innovator...

Canntab Closes Final Tranche of Private Placement for Aggregate Proceeds of $3.7m Canada NewsWire TORONTO, March 16, 2020 TORONTO , March 16, 2020 /CNW/ - Canntab Therapeutics Limited ( CSE:PILL.CN )( OTCQB:CTABF ) ( FRA:TBF1.F ) (the " Company " or " Canntab "), the lead...

Canntab Announces Replacement of Advisor Warrants and Intention to Appoint Larry Latowsky as Director and Executive Chairman of the Board Canada NewsWire TORONTO, March 6, 2020 TORONTO , March 6, 2020 /CNW/ - Canntab Therapeutics Limited ( CSE:PILL.CN )( OTCQB:CTABF ...

Vancouver, British Columbia--(Newsfile Corp. - February 25, 2020) - Canntab Therapeutics (CSE: PILL) (OTCQX: CTABF) (FSE: TBF1), a leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic application, has been granted a Cannabis Research Licence by Health Canada. T...

Canntab Awarded Health Canada Cannabis Research Licence Canada NewsWire TORONTO, Feb. 24, 2020 TORONTO , Feb. 24, 2020 /CNW/ - Canntab Therapeutics Limited ( CSE:PILL.CN )( OTCQB:CTABF ) ( FRA:TBF1.F ) (the " Company " or " Canntab "), the leading innovator in cannabinoid...

TORONTO , Feb. 6, 2020 /PRNewswire/ - Canntab Therapeutics Limited ( CSE:PILL.CN )( OTCQB:CTABF ) ( FRA:TBF1.F ) (the " Company " or " Canntab "), the leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic application, is pleased to announce that it is launc...

The final step to obtain a licence to process Canntab's cannabis hard pill formulation, at its fully built out Markham, Ontario facility. Retains Larry Latowsky , former CEO of Katz Group Canada and its flagship holding Rexall, as an advisor in order to strengthen Canntab's commerci...

TORONTO, Ontario , Nov. 20, 2019 /PRNewswire/ -- Canntab Therapeutics Limited (CSE: PILL.CN) (OTCQB: CTABF) (FRA: TBF1.F) (the "Company" or "Canntab"), the leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic application, today announced the signing o...